Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2007

01-06-2007 | Case Report

Thrombotic Thrombocytopenic Purpura and Bone Marrow Necrosis Associated with Disseminated Gastric Cancer

Authors: Zaher K. Otrock, Ali T. Taher, Jawad A. Makarem, Mireille M. Kattar, Ghazi Nsouli, Ali I. Shamseddine

Published in: Digestive Diseases and Sciences | Issue 6/2007

Login to get access

Excerpt

Thrombotic thrombocytopenic purpura (TTP) is a disseminated form of thrombotic microangiopathy. Severe deficiency of the von Willebrand factor (VWF)-cleaving protease, now denoted ADAMTS-13, is known to be responsible for the formation of platelet thrombi in the microvasculature which is believed to be the pathophysiological hallmark of acute idiopathic TTP [1]. The classic pentad of clinical findings consists of fever, microangiopathic hemolytic anemia (MAHA), thrombocytopenia, fluctuating neurologic impairment, and renal dysfunction [2]. Although most cases are idiopathic, the association of TTP with malignancy is well recognized [3]. About half of malignancy-associated TTP pertains to gastric carcinoma [4]. It usually occurs at the terminal stage of cancer and is extremely rare as the initial presentation of the disease. Bone marrow necrosis (BMN) is another relatively uncommon entity, partly because it is underdiagnosed. It is defined pathologically as the necrosis of hematopoietic tissue and medullary stroma in large areas of the bone marrow, with preservation of bone [5]. We report here on a patient with the rare association of TTP and BMN displayed as the first manifestation of an advanced gastric cancer. …
Literature
1.
go back to reference Kremer Hovinga JA, Studt JD, Lammle B (2003) The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP). Pathophysiol Haemost Thromb 33:417–421PubMedCrossRef Kremer Hovinga JA, Studt JD, Lammle B (2003) The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP). Pathophysiol Haemost Thromb 33:417–421PubMedCrossRef
2.
go back to reference George JN (2000) How I treat patients with thrombotic thrombocytopenic purpura—hemolytic uremic syndrome. Blood 96:1223–1229PubMed George JN (2000) How I treat patients with thrombotic thrombocytopenic purpura—hemolytic uremic syndrome. Blood 96:1223–1229PubMed
3.
4.
go back to reference Murgo AJ (1987) Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 24:161–177PubMed Murgo AJ (1987) Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 24:161–177PubMed
6.
go back to reference Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325:393–397PubMedCrossRef Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325:393–397PubMedCrossRef
7.
go back to reference Nordstrom B, Strang P (1993) Microangiopathic hemolytic anemia (MAHA) in cancer. A case report and review. Anticancer Res 13:1845–1849PubMed Nordstrom B, Strang P (1993) Microangiopathic hemolytic anemia (MAHA) in cancer. A case report and review. Anticancer Res 13:1845–1849PubMed
8.
go back to reference Paydas S, Ergin M, Baslamisli F, Yavuz S, Zorludemir S, Sahin B, Bolat FA (2002) Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Am J Hematol 70:300–305PubMedCrossRef Paydas S, Ergin M, Baslamisli F, Yavuz S, Zorludemir S, Sahin B, Bolat FA (2002) Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Am J Hematol 70:300–305PubMedCrossRef
9.
go back to reference Pirrotta MT, Bucalossi A, Forconi F, Bocchia M, Mazzotta S, Sammassimo S, Gozzetti A, Lauria F (2005) Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma. Oncologist 10:299–300PubMedCrossRef Pirrotta MT, Bucalossi A, Forconi F, Bocchia M, Mazzotta S, Sammassimo S, Gozzetti A, Lauria F (2005) Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma. Oncologist 10:299–300PubMedCrossRef
10.
go back to reference Gonzalez N, Rios E, Martin-Noya A, Rodriguez JM (2002) Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm. Haematologica 87:ECR01PubMed Gonzalez N, Rios E, Martin-Noya A, Rodriguez JM (2002) Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm. Haematologica 87:ECR01PubMed
11.
go back to reference Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP (1979) Microangiopathic hemolytic anemia and cancer: a review. Medicine 58:377–384PubMedCrossRef Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP (1979) Microangiopathic hemolytic anemia and cancer: a review. Medicine 58:377–384PubMedCrossRef
Metadata
Title
Thrombotic Thrombocytopenic Purpura and Bone Marrow Necrosis Associated with Disseminated Gastric Cancer
Authors
Zaher K. Otrock
Ali T. Taher
Jawad A. Makarem
Mireille M. Kattar
Ghazi Nsouli
Ali I. Shamseddine
Publication date
01-06-2007
Published in
Digestive Diseases and Sciences / Issue 6/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9407-7

Other articles of this Issue 6/2007

Digestive Diseases and Sciences 6/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.